Basseterre, St. Kitts, February 12, 2021 (SKNIS): St. Kitts & Nevis’ Chief Medical Officer, Dr. Hazel Laws, said that the procurement in the first instance of 21, 600 doses of the COVID-19 Vaccine, will provide coverage for 20 percent of the national population.
She said this during the National Emergency Operations Center (NEOC) COVID-19 Press Briefing on February 10. “The doses are the product of AstraZeneca and Oxford University vaccines,” she said.
“The start date for delivery can be as early as mid to late February, however, there were some conditions where the specific date of delivery would be dependent on the WHO Emergency Use List Approval Process and some other steps which include our own implementation of our vaccination plan and our regulatory preparedness,” said Dr. Laws.
“It specified that about 25 – 35% of the amount will be supplied in the first quarter and about 65-75% in the second quarter,” she said.
“The data from the clinical trials suggest that it offers a 62 percent efficacy, but the clinical trials have since found that the vaccine had an efficacy of about 82 percent when two doses were given 12 weeks apart,” said Dr. Laws.
Saturday, April 18
Trending
- Minister of National Security Convenes High-Level Security Meeting Amid Recent Spike in Criminal Activity
- Own Your Summer Initiative Launched to Support Youth Engagement Across St. Kitts and Nevis
- PRIME MINISTER DREW COMMENDS LAW ENFORCEMENT OFFICERS, HAILS LANDMARK SECURITY TRAINING AS MAJOR BOOST TO NATIONAL READINESS
- GOVERNMENT, ISTEAM FORMALISE AGREEMENT TO STRENGTHEN INTERGENERATIONAL ENGAGEMENT
- DOCUMENTS OFF TO UNESCO TO APPLY FOR SKN CHRISTMAS SPORTS TO GET ON REPRESENTATIVE LIST OF ICH
- DOCUMENTS OFF TO UNESCO TO APPLY FOR SKN CHRISTMAS SPORTS TO GET ON REPRESENTATIVE LIST OF ICH
- Saint Kitts and Nevis Honoured at Centennial Celebration of the District of Columbia Society of the Order of Founders and Patriots of America
- The Embassy of Saint Kitts and Nevis in Havana Proudly Announces the Fourth Biennial Patriotic Fair

